Key Takeaways
- HSBC cut Nike’s rating from “Buy” to “Hold” and set a $48 price target amid expectations of prolonged recovery and declining revenues
- Shares opened at $42.59, hovering close to the 52-week bottom of $42.36, down sharply from the $80.17 yearly peak
- The athletic footwear giant confronts approximately $1.5 billion in additional yearly expenses due to tariffs imposed by the United States
- HSBC projects global athletic apparel market expansion of roughly 3.9% in 2026, while anticipating Nike will cede share to competitors including Adidas, On, and Arc’teryx
- Insider confidence shown as two board members purchased shares in early April, including Robert Holmes Swan’s ~$500,000 investment
The athletic footwear giant’s shares have plummeted to territory unseen for more than ten years, prompting Wall Street analysts to reassess their stance.
On April 13, HSBC revised its rating on NKE downward from “Buy” to “Hold,” establishing a $48 price objective. This target represents approximately 12.7% potential appreciation from current trading levels — hardly an enthusiastic projection.
The investment bank’s analysis was straightforward. Nike’s recovery efforts are progressing more slowly than anticipated. Analysts expect revenues to contract in upcoming quarters, with earnings projections reduced accordingly. Meanwhile, cost challenges continue mounting.
Shares started Monday’s session at $42.59, barely exceeding the annual low of $42.36. The stock has surrendered nearly 50% of its value from the 52-week peak of $80.17. Current market capitalization hovers around $63 billion.
HSBC isn’t alone in its cautious reassessment. Citigroup reduced its price objective from $65 down to $53. Piper Sandler lowered its forecast from $60 to $50. Evercore adjusted downward from $69 to $57 while maintaining an “outperform” stance. Guggenheim decreased from $77 to $74 but retained its “buy” recommendation. The average rating among 36 Wall Street analysts currently stands at “Hold,” with a mean price target of $62.34.
Tariff Burden Mounting
A significant headwind pressuring shares involves tariff exposure. HSBC calculates that Nike confronts $1.5 billion in extra annual expenses stemming from U.S. import tariffs. Adidas faces a €200 million impact projected for 2026. Given Nike’s extensive overseas manufacturing footprint, near-term mitigation options remain limited.
HSBC’s industry analysis highlighted increased promotional activity throughout Western regions as Nike addresses its inventory surplus. China presents compounded challenges — deteriorating macroeconomic fundamentals paired with intensifying domestic competition are eroding the company’s position.
Globally, the athletic apparel sector is forecast to expand approximately 3.9% in 2026, with the Asia-Pacific region driving growth. However, HSBC anticipates Nike surrendering market share to competitors such as Adidas alongside emerging brands On and Arc’teryx.
Nike’s third-quarter financial results, announced March 31, marginally exceeded expectations. Earnings per share reached $0.35 compared with the consensus forecast of $0.29. Revenue totaled $11.28 billion, narrowly surpassing the $11.23 billion estimate. Year-over-year revenue advanced just 0.1%. By comparison, the corresponding period last year produced $0.54 in EPS.
Board Members Show Confidence
Despite analyst skepticism, some insiders are demonstrating conviction. Two Nike directors acquired shares during early April. Robert Holmes Swan bought 11,781 shares at $42.44 each, representing approximately $500,000 in value. This transaction expanded his ownership stake by 27.2%. Director John W. Rogers Jr. purchased 4,000 shares at $43.34, an investment totaling $173,360 that increased his holdings by 10.8%.
Institutional investors control 64.25% of outstanding shares. Brighton Jones LLC expanded its position by 388.5% during the fourth quarter of last year, accumulating over 160,000 additional shares.
Wall Street analysts currently forecast Nike will deliver full-year earnings of $2.05 per share for the ongoing fiscal period. The price-to-earnings ratio stands at 28.21. The stock’s 50-day moving average sits at $56.46 while the 200-day average registers $62.07 — both substantially above present trading levels.
